Cargando…
Size matters: second breast cancer size following treatment for primary cancer as a predictor of survival
Autores principales: | MacLennan, GS, Lawrence, G, Boachie, C, Heys, SD, Gilbert, FJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978814/ http://dx.doi.org/10.1186/bcr2650 |
Ejemplares similares
-
Surveillance following breast cancer: is it cost-effective?
por: Ternent, L, et al.
Publicado: (2010) -
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
por: MacLennan, Graeme, et al.
Publicado: (2013) -
Clinical, angiographic, and electrocardiographic predictors of infarct size and microvascular obstruction sssessed by MRI
por: Thiele, Holger, et al.
Publicado: (2009) -
When is a randomised controlled trial required: the theoretical domains framework approach
por: Campbell, Marion, et al.
Publicado: (2013) -
Determining items for inclusion in a decision support intervention for clinical trial participation: a modified Delphi approach
por: Gillies, Katie, et al.
Publicado: (2013)